Kudlay Dmitry Anatolyevich
Leading Researcher of the Laboratory of Personalized Medicine and Molecular Immunology of the Federal State Budgetary Institution "State Research Center Institute of Immunology" FMBA of Russia, Doctor of Medical Sciences, Professor of the Department of Pharmacology of the Institute of Pharmacy of the Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), vice president for the introduction of new medical technologies of the Biotechnopark "Generium". The direction of scientific and practical activity - fundamental and practical medical biotechnology, immunobiotechnology, molecular diagnostics, cell therapy. The area of scientific research is the development, scaling and implementation into practice of therapeutic proteins and biomedical cell products for the diagnosis and treatment of severe socially significant diseases.
Member of the editorial board of the journals "Pharmaceutical Business and Medicinal Technologies", "Thrombosis, Hemostasis and Rheology" and "Tuberculosis and Lung Diseases". I am a member of EBTNA (European Thematic Biotechnology Network Association), FABA (Federation of Asian Biotechnology Associations), AABB (American Association of Blood Banks), National Association of Thrombosis Specialists, Clinical Hemostasiology and Hemorheology, Russian and Clinical Society of Hemophilia Specialists, "National Association of Experts in the Field of Primary Immunodeficiencies". Author of 270 scientific works, including 7 monographs, practical recommendations and 1 patent for an invention (Hirsch index - 24), there are publications in foreign scientific journals: "Allergy", "European Respiratory Journal", "Pediatric Respiratory Reviews", "Blood », Hemophilia, Cells, etc. I am a member of the Council for the priority direction of scientific and technological development of the Russian Federation "Transition to personalized medicine, high-tech healthcare and healthcare technologies, including through the rational use of drugs", expert of the Council for the development of the pharmaceutical industry of the Ministry of Industry and Trade of Russia in terms of innovative products Programs EAEU, strategies for the development of the pharmaceutical industry of the Russian Federation "Pharma 2020" and "Pharma 2030", the Interdepartmental Committee of the Russian Academy of Sciences on the formation of the national drug policy.